Skip to main content
. 2015 May 28;2015:959107. doi: 10.1155/2015/959107

Table 1.

Species identified using 16S sequencing, with smear status, HIV status, and CD4 counts (n = 232).

Species Number isolated
(% of group)
Number (%)
smear positive
Number with mixed species4 HIV prevalence1 (%) Median CD42 (cells/µL)
(range (number included))
Clinic patient group
 M. avium complex 25 (26) 2 (8) 5 8/10 87 (14, 827 [5])
 M. kansasii 21 (22) 6 (29) 3 5/8 85 (39, 763 [5])
 M. parascrofulaceum 9 (9) 1 (11) 0 3/3 102 (66, 138 [2])
 M. fortuitum 9 (9) 2 (22) 1 1/1 [0]
 M. gordonae 7 (7) 0 1 1/1 195 [1]
 New species 7 (7) 1 (14) 0 3/3 475 (236, 512 [3])
 Other species 18 (19) 0 2 4/5 291.5 (154, 492 [4])

 Total 96 12 (12.5) 12 (12.5% of 96 isolates) 25/31 (80.6) 215.5 (14, 827 [20])

Pre-IPT3 screening group
 M. gordonae 53 (39) 8 (15) 5 10/12 298 (66, 396 [8])
 M. kansasii 29 (21) 11 (38) 1 9/14 183.5 (69, 544 [8])
 M. avium complex 13 (10) 0 3 4/5 211 (92, 534 [4])
 M. parascrofulaceum 12 (9) 2 (17) 1 1/2 223 [1]
 M. fortuitum 11 (8) 0 1 3/5 358 (245, 471 [2])
 M. szulgai 5 (4) 0 2 2/2 132.5 (123, 142 [2])
 New species 3 (2) 0 0 0/0 [0]
 Other species 10 (7) 0 2 3/3 311 (252, 370 [2])

 Total 136 21 (15.4) 15 (11.0% of 136 isolates) 32/43 (74.4) 245 (66, 544 [27])

1Fisher's exact test for difference in HIV prevalence by species, both groups combined, P = 0.79.

2Median CD4 count by species for those known to be HIV-positive, combining both groups (clinic patients and IPT screening group) and including 8 species compared using Kruskal-Wallis test, which showed no evidence for difference by species, P = 0.42.

3IPT: isoniazid preventive therapy.

4For specimens containing mixed NTM species on PCR sequencing, the main species is reported; minority species were not identified, but the numbers with mixed species are given here. This does not apply to those with concurrent M. tuberculosis, who were excluded from this study.